Adults whose type 2 diabetes was treated with GLP-1 receptor agonists were more likely to develop co...
New Kink in the Link Between GLP-1 Drugs and Cognition
Adults whose type 2 diabetes was treated with GLP-1 receptor agonists were more likely to develop cognitive impairment over 10 years than their counterparts...
Author: MedPage Today
Read Original Article